153 related articles for article (PubMed ID: 38504418)
1. Cerebellar phenotypes in germline PTEN mutation carriers.
Gambini D; Ferrero S; Bulfamante G; Pisani L; Corbo M; Kuhn E
Neuropathol Appl Neurobiol; 2024 Apr; 50(2):e12970. PubMed ID: 38504418
[TBL] [Abstract][Full Text] [Related]
2. Imaging of PTEN-related abnormalities in the central nervous system.
Dhamija R; Hoxworth JM
Clin Imaging; 2020 Apr; 60(2):180-185. PubMed ID: 31927175
[TBL] [Abstract][Full Text] [Related]
3. PTEN inactivation by germline/somatic c.950_953delTACT mutation in patients with Lhermitte-Duclos disease manifesting progressive phenotypes.
Chen XY; Lu F; Wang YM; Yang Y; Wei GQ; Wu D; Wang LF; Wu YM
Clin Genet; 2014 Oct; 86(4):349-54. PubMed ID: 24102544
[TBL] [Abstract][Full Text] [Related]
4. Cowden disease and Lhermitte-Duclos disease: characterization of a new phakomatosis.
Robinson S; Cohen AR
Neurosurgery; 2000 Feb; 46(2):371-83. PubMed ID: 10690726
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment of cancer-prone germline PTEN mutant mice with low-dose rapamycin extends lifespan and delays tumour development.
Tibarewal P; Rathbone V; Constantinou G; Pearce W; Adil M; Varyova Z; Folkes L; Hampson A; Classen GAE; Alves A; Carvalho S; Scudamore CL; Vanhaesebroeck B
J Pathol; 2022 Dec; 258(4):382-394. PubMed ID: 36073856
[TBL] [Abstract][Full Text] [Related]
6. A heterozygous frameshift mutation of the PTEN/MMAC1 gene in a patient with Lhermitte-Duclos disease - only the mutated allele was expressed in the cerebellar tumor.
Iida S; Tanaka Y; Fujii H; Hayashi S; Kimura M; Nagareda T; Moriwaki K
Int J Mol Med; 1998 Jun; 1(6):925-9. PubMed ID: 9852626
[TBL] [Abstract][Full Text] [Related]
7. Cancer risk and genotype-phenotype correlations in PTEN hamartoma tumor syndrome.
Nieuwenhuis MH; Kets CM; Murphy-Ryan M; Yntema HG; Evans DG; Colas C; Møller P; Hes FJ; Hodgson SV; Olderode-Berends MJ; Aretz S; Heinimann K; Gómez García EB; Douglas F; Spigelman A; Timshel S; Lindor NM; Vasen HF
Fam Cancer; 2014 Mar; 13(1):57-63. PubMed ID: 23934601
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer risk and clinical implications for germline PTEN mutation carriers.
Ngeow J; Sesock K; Eng C
Breast Cancer Res Treat; 2017 Aug; 165(1):1-8. PubMed ID: 26700035
[TBL] [Abstract][Full Text] [Related]
9. Lhermitte-Duclos Disease (Dysplastic Gangliocytoma of the Cerebellum) and Cowden Syndrome: Clinical Experience From a Single Institution with Long-Term Follow-Up.
Jiang T; Wang J; Du J; Luo S; Liu R; Xie J; Wang Y; Li C
World Neurosurg; 2017 Aug; 104():398-406. PubMed ID: 28479525
[TBL] [Abstract][Full Text] [Related]
10. Severe Lhermitte-Duclos disease with unique germline mutation of PTEN.
Sutphen R; Diamond TM; Minton SE; Peacocke M; Tsou HC; Root AW
Am J Med Genet; 1999 Feb; 82(4):290-3. PubMed ID: 10051160
[TBL] [Abstract][Full Text] [Related]
11. PTEN hamartoma tumour syndrome: what happens when there is no PTEN germline mutation?
Yehia L; Eng C
Hum Mol Genet; 2020 Oct; 29(R2):R150-R157. PubMed ID: 32568377
[TBL] [Abstract][Full Text] [Related]
12. WWP1 Gain-of-Function Inactivation of PTEN in Cancer Predisposition.
Lee YR; Yehia L; Kishikawa T; Ni Y; Leach B; Zhang J; Panch N; Liu J; Wei W; Eng C; Pandolfi PP
N Engl J Med; 2020 May; 382(22):2103-2116. PubMed ID: 32459922
[TBL] [Abstract][Full Text] [Related]
13. Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults.
Zhou XP; Marsh DJ; Morrison CD; Chaudhury AR; Maxwell M; Reifenberger G; Eng C
Am J Hum Genet; 2003 Nov; 73(5):1191-8. PubMed ID: 14566704
[TBL] [Abstract][Full Text] [Related]
14. Lhermitte-Duclos disease with neurofibrillary tangles in heterotopic cerebral grey matter.
Rusiecki D; Lach B
Folia Neuropathol; 2016; 54(2):190-6. PubMed ID: 27543776
[TBL] [Abstract][Full Text] [Related]
15. Association between Cowden syndrome and Lhermitte-Duclos disease: report of two cases and review of the literature.
Derrey S; Proust F; Debono B; Langlois O; Layet A; Layet V; Longy M; Fréger P; Laquerrière A
Surg Neurol; 2004 May; 61(5):447-54; discussion 454. PubMed ID: 15120218
[TBL] [Abstract][Full Text] [Related]
16. Dysplastic gangliocytoma (Lhermitte-Duclos disease) associated with Cowden disease: report of a case and review of the literature for the genetic relationship between the two diseases.
Murata J; Tada M; Sawamura Y; Mitsumori K; Abe H; Nagashima K
J Neurooncol; 1999 Jan; 41(2):129-36. PubMed ID: 10222433
[TBL] [Abstract][Full Text] [Related]
17. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.
Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C
PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080
[TBL] [Abstract][Full Text] [Related]
18. Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model.
Mester JL; Tilot AK; Rybicki LA; Frazier TW; Eng C
Eur J Hum Genet; 2011 Jul; 19(7):763-8. PubMed ID: 21343951
[TBL] [Abstract][Full Text] [Related]
19. Exome sequencing reveals germline gain-of-function
Colby S; Yehia L; Niazi F; Chen J; Ni Y; Mester JL; Eng C
Cold Spring Harb Mol Case Stud; 2016 Nov; 2(6):a001230. PubMed ID: 27900366
[TBL] [Abstract][Full Text] [Related]
20. Dynamics and structural stability effects of germline PTEN mutations associated with cancer versus autism phenotypes.
Smith IN; Thacker S; Jaini R; Eng C
J Biomol Struct Dyn; 2019 Apr; 37(7):1766-1782. PubMed ID: 29663862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
